---
figid: PMC6760332__en.2019-00337f2
figtitle: Strategies for developing therapeutics for lipid mediators
organisms:
- NA
pmcid: PMC6760332
filename: en.2019-00337f2.jpg
figlink: pmc/articles/PMC6760332/figure/fig2/
number: F2
caption: Strategies for developing therapeutics for lipid mediators. Using 12,13-diHOME
  as an example, we highlight how upstream, on-target, or downstream parts of the
  biosynthetic pathway could and have been targeted in potential therapeutic strategies
  to treat human metabolic disease.
papertitle: Lipokines and Thermogenesis.
reftext: Matthew D Lynes, et al. Endocrinology. 2019 Oct;160(10):2314-2325.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5298494
figid_alias: PMC6760332__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC6760332__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6760332__en.2019-00337f2.html
  '@type': Dataset
  description: Strategies for developing therapeutics for lipid mediators. Using 12,13-diHOME
    as an example, we highlight how upstream, on-target, or downstream parts of the
    biosynthetic pathway could and have been targeted in potential therapeutic strategies
    to treat human metabolic disease.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - be
  - Cyp4g1
  - Cyp4d1
  - Cyp4d2
  - Cyp4ae1
  - Cyp18a1
  - Cpr
  - Cyp4e3
  - Cyp6a2
  - Cyp9b1
  - Cyp9b2
  - Cyp4e2
  - Cyp6a9
  - Cyp6a20
  - Cyp6a21
  - Cyp6a8
  - Cyp9c1
  - Cyp4d8
  - Cyp12a4
  - Cyp4c3
  - Cyp4e1
  - Cyp4p1
  - Cyp6a22
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Is
  - thi
  - thiv
  - an
  - mas
  - myoblast-specific
  - Linoleic acid
  - epoxide
  - glucuronides
  - Linoleic Acid
---
